Hexagon Capital Partners LLC - CYTOSORBENTS CORP ownership

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$6,266
-47.6%
3,3330.0%0.00%
-33.3%
Q2 2023$11,965
+6.5%
3,3330.0%0.00%0.0%
Q1 2023$11,232
+117.4%
3,3330.0%0.00%
+50.0%
Q4 2022$5,166
+3.3%
3,3330.0%0.00%
+100.0%
Q3 2022$5,000
-28.6%
3,3330.0%0.00%
-50.0%
Q2 2022$7,000
-36.4%
3,3330.0%0.00%
-33.3%
Q1 2022$11,000
-21.4%
3,3330.0%0.00%
-25.0%
Q4 2021$14,000
-48.1%
3,3330.0%0.00%
-50.0%
Q3 2021$27,000
+8.0%
3,3330.0%0.01%
+14.3%
Q2 2021$25,000
-10.7%
3,3330.0%0.01%
-12.5%
Q1 2021$28,000
+7.7%
3,3330.0%0.01%0.0%
Q4 2020$26,0000.0%3,3330.0%0.01%0.0%
Q3 2020$26,0003,3330.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 249,430$2,015,0001.24%
Manatuck Hill Partners, LLC 194,100$1,568,0000.81%
Skylands Capital, LLC 495,850$4,006,0000.66%
EAM Global Investors LLC 78,027$630,0000.34%
EAM Investors, LLC 107,531$869,0000.24%
Granahan Investment Management 278,170$2,248,0000.16%
Wealthcare Advisory Partners LLC 62,079$502,0000.10%
Avenir Corp 76,390$617,0000.08%
Crow Point Partners, LLC 48,576$380,0000.07%
Kalos Management, Inc. 14,700$120,0000.06%
View complete list of CYTOSORBENTS CORP shareholders